Johnson & Johnson settles with New York over opioid epidemic
Danielle Wiener-Bronner reports for CNN that Johnson & Johnson, the pharmaceutical giant responsible for one of the three COVID-19 vaccines in the United States, will pay New York a $230 million settlement, over the pharmaceutical company's role in the opioid epidemic. "Johnson & Johnson helped fuel this fire," New York Attorney General Letitia James said in a statement June 26. "While no amount of money will ever compensate for the thousands who lost their lives or became addicted to opioids across our state ... these funds will be used to prevent any future devastation." The money will be used for opioid education, prevention, and treatment. In a press release, Johnson & Johnson said that "the settlement is not an admission of liability or wrongdoing," adding that it "remains committed to providing certainty for involved parties and critical assistance for communities in need." The settlement gets Johnson & Johnson off the hook for a New York lawsuit against the makers and distributors of opioids that goes to trial next week. Read more about this story at CNN.